What is autoimmune connective tissue disease?
In autoimmune connective tissue disease the immune system targets the body's own tissues, producing inflammation that can involve joints, skin, muscle, blood vessels and internal organs simultaneously. Systemic lupus erythematosus, Sjögren's syndrome, inflammatory myositis, mixed connective tissue disease, antiphospholipid syndrome and the vasculitides all belong to this group.
Because symptoms are spread across organ systems, these conditions are often investigated piecemeal for years. A rheumatology and immunology assessment brings them together: pattern recognition on examination, targeted antibody testing, and screening of the organs each condition is known to affect.
Symptoms to watch for
- Persistent unexplained fatigue with joint or muscle pain
- Facial or sun-sensitive rashes, or rashes over the knuckles
- Recurrent mouth or nose ulcers
- Persistently dry eyes and dry mouth
- Unexplained recurrent fever or weight loss
- Hair loss, or fingers changing colour in the cold
- Muscle weakness climbing stairs or lifting the arms
- Blood or protein found in the urine, or unexplained anaemia
- Recurrent miscarriage or unexplained blood clots
When to seek urgent care
New chest pain, breathlessness, seizure, sudden vision change, reduced urine output or a rapidly spreading rash needs immediate assessment.
How it is diagnosed
Investigation is chosen to answer a specific question rather than as a blanket screen. For autoimmune and connective tissue disease that usually means:
- Systematic history and examination across skin, joints, muscle and organ systems
- ANA followed by extended antibody profiling (anti-dsDNA, ENA, myositis and antiphospholipid panels)
- Complement levels, inflammatory markers, full blood count
- Urinalysis and renal function to detect kidney involvement early
- ANCA testing where vasculitis is suspected
- Imaging, nerve conduction, muscle enzymes or biopsy where indicated
Treatment options at Siva Sakthi
Which of these applies to you depends on what the assessment shows. The options are discussed with you, including what each involves and what recovery looks like.
- HydroxychloroquineA foundation treatment in lupus and related disease, reducing flares and organ damage, with periodic eye screening.
- CorticosteroidsUsed to bring active disease under control quickly, then tapered to the lowest effective dose.
- Immunosuppressive therapyMycophenolate, azathioprine, methotrexate or cyclophosphamide, selected according to which organs are involved.
- Biologic therapyTargeted agents such as rituximab or belimumab in selected refractory or organ-threatening disease.
- Organ-specific careRenal, pulmonary, neurological, ophthalmic and obstetric input coordinated as required.
- Preventive careVaccination, bone protection, cardiovascular risk reduction, sun protection and pregnancy planning.
- MonitoringScheduled review with bloods and urinalysis to detect flares and drug toxicity before they cause harm.
Common questions
No. A low-titre positive ANA is found in many healthy people, particularly women. It has meaning only alongside symptoms, examination findings and more specific antibodies — which is why it should be interpreted by a rheumatologist.
There is a genetic predisposition, so autoimmune disease clusters in families, but they are not directly inherited and most relatives never develop one.
Yes. Many patients achieve prolonged remission or low disease activity on treatment. Monitoring continues because flares can occur after long quiet periods.
For most women, yes, with planning. Pregnancy is safest when disease has been quiet for several months and medication has been reviewed for compatibility beforehand.
Book a consultation in Guntur
Autoimmune & Connective Tissue Disease is assessed and treated by Dr. Deepika Ponnuru, MD (Internal Medicine), DM (Rheumatology), at our Kothapeta clinic. Request an appointment or call +91 00000 00000.